PD-159 Mutation in the tyrosine kinase domain of epidermal...

Lung Cancer 2005 / 7 Vol. 49

PD-159 Mutation in the tyrosine kinase domain of epidermal growthfactor receptor (EGFR) is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (NSCLC)

Tsai, C., Chiu, C., Chou, T., Li, L., Chang, K., Chen, Y., Tsai, S., Perng, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80492-1
Date:
July, 2005
File:
PDF, 139 KB
english, 2005
Conversion to is in progress
Conversion to is failed